Methods of diagnosing and treating pre-eclampsia or eclampsia
CA 2922031 C · Owner: Beth Israel Deaconess Medical Center, Inc. · Inventors: Sukhatme, Vikas P.; Maynard, Sharon; Karumanchi, S. Ananth
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Disclosed herein are methods for diagnosing pre-eclampsia and eclampsia. Also disclosed herein are methods for treating pre-eclampsia and eclampsia using compounds that increase VEGF or PIGF levels or compounds that decrease sFlt-1 levels. Compounds that inhibit the binding of VEGF or PIGF to SFlt1 - are also disclosed herein for the treatment of pre-eclampsia or eclampsia.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 21, 2003 and granted December 15, 2020. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 21, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 21, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.